Last edition
News about "Superluminal Medicines"
Superluminal and Eli Lilly Partner on Next-Gen Cardiometabolic and Obesity Treatments
Superluminal Medicines has announced a collaboration with Eli Lilly and Company to advance small molecule therapeutics for cardiometabolic diseases and obesity.
Superluminal Medicines | 16/08/2025 | By Dineshwori | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members